Homepage
Sampling Human Subsidiary Xeno Wins Entrepreneurial Project of the Year Award from Czech Ministry for Industry and Trade
Xeno Cell Innovations won an award in the “Applications” program for “extraordinary social contribution.” Xeno is a subsidiary of Sampling Human, which CEO Daniel Georgiev co-founded in the Czech Republic in 2016. Read post
Umaro Is on C&E News’ Radar
There’s nothing quite like a crispy piece of bacon. But the pork industry releases more greenhouse gases than the entire country of Germany each year, according to the Food and Agriculture Organization of the United Nations. While some companies make plant-based bacon, the start-up Umaro Foods says existing products lack the key characteristic that makes bacon delicious: crispiness. Read post
Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine
The funding will advance development of Ray Therapeutics’ optogenetics technology platform. The company will advance RTx-021 for the treatment of geographic atrophy age-related macular degeneration. Read post Umaro, HOPO Win Joint ARPA-E Funding to Extract Rare Earth Elements from Seaweed
Umaro Foods will leverage advancements in HOPO Therapeutics’ chelator technology to efficiently extract rare earth elements and platinum group metals from seaweeds. They will be applying advanced metal chelator molecules to selectively extract metals in a non-destructive manner from process streams producing valuable food-grade seaweed proteins and commodities such as agar, alginate, and carrageenan. Read post
Navneet Matharu & Jenny Hamilton Win $2 Million in Seed Funding
Matharu, an Assistant Professor at UC San Francisco, is studying genetic disorders that have high unmet needs, and developing non-editing forms of CRISPR-based therapeutics. Matharu cofounded Regel Therapeutics, a Bakar Labs tenant, in 2021. “This is an extremely meaningful award from the HS Chau Foundation,” says Matharu.” This funding will enable us to utilize our foundational technology to diversify and expand the therapeutic development pipelines at Regel.” Read post
Via Nova Therapeutics Announces FDA Clearance of IND Application for VNT-101, a Novel Direct-Acting Antiviral Against Influenza A Virus
“We look forward to evaluating VNT-101 in the clinic,” said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. “This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic.” Read post
Investment Update: Bakar Labs Elevates UC Berkeley as Top Hub for Startups
Since joining Bakar Labs, 16 tenant companies have brought in $284 million from a network of 72 funds, including angel, corporate, and VC firms, including a16z, Bessemer Venture Partners, Deerfield Management, GV, J&J Innovation, Morningside, MRL Ventures, Novartis, Novo Holdings, S32, and venBio. Read postOur affiliates
Ready to run?
Startups need to focus on making milestones, not managing equipment.
Bakar Labs maintains tissue culture facilities, a freezer farm, fume hoods, basic benchtop equipment and plenty of analytical instruments. Optional lab support services can also make for quick starts that help get results fast.
At UC Berkeley
Bakar Labs is just steps from UC Berkeley’s world-renowned faculty and more than 40,000 students who train in top programs including science, engineering, law and business. Dotting the campus is a network of core facilities that feature a wide range of advanced equipment and services for use by startups. Recruiting student talent and scientific co-founders couldn’t be easier.
Today’s best startups blaze a trail all their own, but they don’t do it alone.
They build their support network to help them navigate the multiple challenges they face. At Bakar Labs, tenants join a community of as many as 50 like-minded teams willing to share the scientific and business insights that help them advance. The incubator spans more than 40,000 square feet of lab and office spaces within the fully renovated Woo Hon Fai Hall, the iconic former home of the Berkeley Art Museum. With so much going on, investors, industry partners and new talent are already taking notice.
Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.
